col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


34 Ergebisse       Seite 1

 [1] 
Elsevier: Contemporary Clinical Trials Communications
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2023―Dez―20 Moana: Alternate surveillance for COVID-19 in a Unique Population (MASC-UP) Erin R. Morgan, Denise Dillard, Eric Lofgren, Benetick Kabua Maddison, Sheldon Riklon, Pearl McElfish, Ka`imi Sinclair
2 [GO] 2023―Dez―20 Targeted electronic health record-based recruitment strategy to enhance COVID-19 vaccine response clinical research study enrollment Hninn Khine, Alex Mathson, Puleng R. Moshele, Bharat Thyagarajan, Amy B. Karger, Stefani N. Thomas
3 [GO] 2023―Okt―28 Operational changes to the lupus intervention fatigue trial as a result of COVID-19: An update to the study protocol D. Kinnett-Hopkins, R. Ramsey-Goldman, H. Milaeger, J.S. Chmiel, A. Chung, D. Erickson, et al. (+3)
4 [GO] 2023―Jul―17 Design of VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1): A double-blind, randomized placebo-controlled trial of COVID-19 convalescent plasma in hospitalized patients with early respiratory compromise Edward N. Janoff, Sheldon T. Brown, Ilana Belitskaya-Levy, Jeffrey L. Curtis, Robert A. Bonomo, Elliott K. Miller, et al. (+7)
5 [GO] 2023―Mrz―25 COVID-19 and the Physio4FMD trial: Impact, mitigating strategies and analysis plans Louise Marston, Marie Le Novere, Federico Ricciardi, Irwin Nazareth, Alan Carson, Mark Edwards, et al. (+7)
6 [GO] 2023―Mrz―18 Virtual delivery of improvisational movement and social engagement interventions in the IMOVE trial during the COVID-19 pandemic Jason T. Fanning, Rebecca Barnstaple, Phyllis Babcock, Amanda Black, Natasha Collier, M. Constance Linville, et al. (+9)
7 [GO] 2023―Mrz―11 Precision recruitment for high-risk participants in a COVID-19 cohort study Aziz M. Mezlini, Eamon Caddigan, Allison Shapiro, Ernesto Ramirez, Helena M. Kondow-McConaghy, Justin Yang, et al. (+3)
8 [GO] 2023―Mrz―11 An evidence double standard for pharmacological versus non-pharmacological interventions: Lessons from the COVID-19 pandemic Tracy Beth Høeg, Vinay K. Prasad
9 [GO] 2023―Jan―31 The effect of l-carnitine supplementation on mortality and clinical outcomes in ventilator-dependent critically ill patients with obesity and COVID-19: Protocol for a randomized double-blind placebo-controlled trial Seyyed Mostafa Arabi, Saeid Hadi, Parisa Gholambareshi, Leila Sadat Bahrami, Ebrahim Hazrati, Sayid Mahdi Mirghazanfari, et al. (+2)
10 [GO] 2023―Jan―21 Effect of colchicine and aspirin given together in patients with moderate COVID-19 K. Sunil Naik, Niranjan Andhalkar, Sohal Pendse
11 [GO] 2022―Nov―29 FIT Teens RCT for juvenile fibromyalgia: Protocol adaptations in response to the COVID 19 pandemic Susmita Kashikar-Zuck, Kimberly A. Barnett, Sara E. Williams, Megan Pfeiffer, Staci Thomas, Katie Beasley, et al. (+15)
12 [GO] 2022―Nov―13 Revisiting the clinical trial history and regulatory mechanisms in Nepal in the context of COVID-19 pandemic Suman Sharma Paudel, Yunima Sapkota, Pradip Gyanwali, Meghnath Dhimal, Namita Ghimire, Suman Pant, et al. (+2)
13 [GO] 2022―Okt―10 Development of a colorectal cancer screening intervention for Alaska Native people during a pandemic year Christie A. Flanagan, Lila J. Finney Rutten, John B. Kisiel, Jennifer K. Lent, Joseph F. Bachtold, Andrew W. Swartz, Diana G. Redwood
14 [GO] 2022―Aug―17 The impact of COVID-19 restrictions on participant enrollment in the PREPARE trial David Pogorzelski, Paula McKay, Michael J. Weaver, Todd Jaeblon, Robert A. Hymes, Greg E. Gaski, et al. (+392)
15 [GO] 2022―Jul―20 COVIDMED - An early pandemic randomized clinical trial of losartan treatment for hospitalized COVID-19 patients Daniel Freilich, Jennifer Victory, Paul Jenkins, Anne Gadomski
16 [GO] 2022―Jul―04 Plant formulation ATRICOV 452 in improving the level of COVID-19 specific inflammatory markers in patients Latha Damle, Hrishikesh Damle, Bharath BR
17 [GO] 2022―Jun―06 Overcoming COVID-19 disruptions: Innovations in product provision in a multi-national clinical trial among cisgender men, transgender men and transgender women in five countries Jacobson Cindy, Johnson Sherri, Billups Tarana, Mitterer Lynn, Chadza Mary, Gumede Sibuiswe, et al. (+5)
18 [GO] 2022―Jan―12 A first remotely-delivered guided brief intervention to reduce intrusive memories of psychological trauma for healthcare staff working during the ongoing COVID-19 pandemic: Study protocol for a randomised controlled trial Laura Singh, Marie Kanstrup, Beau Gamble, Anahita Geranmayeh, Katarina E. Göransson, Ann Rudman, et al. (+5)
19 [GO] 2021―Nov―16 Adaptations to the RVA breathes clinical trial due to the COVID-19 pandemic Robin S. Everhart, Katherine W. Dempster, Devon Withers, Suzanne E. Mazzeo, Rosalie Corona, Leroy R. Thacker, Michael S. Schechter
20 [GO] 2021―Nov―16 Meeting the challenges of retention and enrollment of study participants in clinical trials during the COVID-19 pandemic from the study leadership perspective: Experience from the Zoster Eye Disease Study (ZEDS) MeeLee Tom, Elisabeth J. Cohen, Carlos LopezJimenez, Judith S. Hochman, Andrea B. Troxel, Bennie H. Jeng
21 [GO] 2021―Jun―26 Implementation of documented and written informed consent for clinical trials of communicable diseases: Lessons learned, barriers, solutions, future directions identified during the conduct of a COVID-19 clinical trial Patricia Woods, Maura Flynn, Paul Monach, Sara Schiller, Erika Holmberg, Sarah Leatherman, et al. (+2)
22 [GO] 2021―Jun―16 Addressing cancer survivors’ cardiovascular health using the automated heart health assessment (AH-HA) EHR tool: Initial protocol and modifications to address COVID-19 challenges Randi E. Foraker, Eleanor C. Davidson, Emily V. Dressler, Brian J. Wells, Simon Craddock Lee, Heidi D. Klepin, et al. (+6)
23 [GO] 2021―Mrz―12 A randomized and comparative study to assess safety and efficacy of supplemental treatment of a herbal formulation - Aayudh Advance comprising essential oils in patients with corona virus 2019 (COVID-19) Jayesh Dutt, Bhavdeep Ganatra, Nilay Suthar, Malek Mohammedebrahim Mohamediqbal, Bhakti Shukla, Krupali Shukla, et al. (+5)
24 [GO] 2021―Feb―10 Effects of neuromuscular electrical stimulation therapy on physical function in patients with COVID-19 associated pneumonia: Study protocol of a randomized controlled trial Marco A. Minetto, Sabrina Dal Fior, Chiara Busso, Pietro Caironi, Giuseppe Massazza, Nicola A. Maffiuletti, Federica Gamna
25 [GO] 2021―Jan―19 Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol X. Solanich, A. Antolí, N. Padullés, M. Fanlo-Maresma, A. Iriarte, F. Mitjavila, et al. (+14)
26 [GO] 2020―Nov―30 Risk and mitigation actions for clinical trials during COVID-19 pandemic (RiMiCOPa) Antonella Bacchieri, Andrea Rossi, Paolo Morelli
27 [GO] 2020―Okt―09 Leveraging analytics to assure quality during the Covid-19 pandemic - The COVACTA clinical study example Timothé Ménard, Rich Bowling, Pooja Mehta, Björn Koneswarakantha, Eileen Magruder
28 [GO] 2020―Okt―09 The IGNITE trial: Participant recruitment lessons prior to SARS-CoV-2 Eric D. Vidoni, Amanda Szabo-Reed, Chaeryon Kang, Ashley R. Shaw, Jaime Perales-Puchalt, George Grove, et al. (+7)
29 [GO] 2020―Okt―07 Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven Richard D. Shih, Dennis G. Maki, Charles H. Hennekens
30 [GO] 2020―Okt―07 A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis plan Paolo Chiodini, Laura Arenare, Maria Carmela Piccirillo, Francesco Perrone, Ciro Gallo
31 [GO] 2020―Sep―23 Health Outcome Predictive Evaluation for COVID 19 international registry (HOPE COVID-19), rationale and design Iván J. Núñez Gil, Vicente Estrada, Cristina Fernández-Pérez, Gisela Feltes, Oscar Vedia, Carlos E. Vergara-Uzcategui, et al. (+11)
32 [GO] 2020―Aug―13 Managing risks of oncology clinical trials during COVID-19 pandemic Roberto J. Arai, Camila M.V. Moniz, André T.C. Chen, Milena P. Mak, Roger Chammas, Paulo M. Hoff
33 [GO] 2020―Jul―30 COVID-19 disparities: An urgent call for race reporting and representation in clinical research Hala T. Borno, Sylvia Zhang, Scarlett Gomez
34 [GO] 2020―Jun―09 The critical role of futility analysis in the pursuit of effective treatments for COVID-19 Zheng Su
 [1] 

34 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec